Citigroup’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,450
Closed -$42K 5777
2021
Q2
$42K Hold
1,450
﹤0.01% 4903
2021
Q1
$38K Hold
1,450
﹤0.01% 4852
2020
Q4
$42K Hold
1,450
﹤0.01% 6162
2020
Q3
$35K Buy
1,450
+1,200
+480% +$27.7K ﹤0.01% 5813
2020
Q2
$5K Buy
+250
New +$4.92K ﹤0.01% 7254

Other funds holding BMEZ

Citigroup's BMEZ Position: Q3 2021 in Review

Citigroup sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2021, closing a stake of 1,450 shares — an estimated $42K sold.

Citigroup first reported a position in BMEZ in Q2 2020 and held it in 5 quarters. The position peaked at $42K in Q2 2021. 67 funds tracked by Wall St. Rank hold BMEZ as of Q3 2021.

  • Citigroup reported no remaining BlackRock Health Sciences Trust II position as of Q3 2021 after selling out during the quarter.
  • Citigroup sold 1,450 BlackRock Health Sciences Trust II shares in Q3 2021, an estimated $42K.
  • Citigroup first reported a position in BlackRock Health Sciences Trust II in Q2 2020 and held it in 5 quarters.
  • Citigroup's BlackRock Health Sciences Trust II position peaked at $42K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2021.

Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.